Introduction
Juvenile myoclonic epilepsy (JME) is a generalized genetic epilepsy (GGE) syndrome, clinically characterized by irregular jerks mainly of shoulders and arms after awakening, with peak of onset between 12 and 18 years, and electroencephalographically by bilateral and synchronous 4-6/s spike and wave complexes, often in the form of polyspike and waves [1] . The main seizure type is myoclonia occurring on awakening, i.e., within 2 h, present in all cases. Around 90% of JME patients have generalized tonic-clonic seizures (GTCS) and 30% absence seizures [1] .
Electrophysiological and functional neuroimaging (fMRI and spectroscopy) studies suggest fronto-thalamic circuitry dysfunction in JME [2] [3] [4] [5] . This network also subserves executive functions and various studies have provided evidence for different degrees of executive dysfunction and prospective memory impairment [6] [7] [8] [9] [10] [11] [12] . Other cognitive functions, such as hippocampal episodic memory, are relatively preserved though there have been reports of more widespread cognitive involvement [13] . The degree of executive deficits in these patients is variable and cognitive dysfunction does not follow a specific pattern on neuropsychological studies [14] . Patients with refractory seizures have worse performance on tests assessing attention and executive function and higher impulsive traits, suggesting an obvious heterogeneity within the same epileptic syndrome, while those with controlled seizures have better performance [15] .
In the last decades, besides non-specific precipitant factors for EEG discharges and seizures, such as sleep deprivation and stress, reflex traits as praxis and language induction, eye-closure and photosensitivity, have been reported [16, 17, [18] [19] [20] . Praxis induction is a reflex trait defined as a precipitation of seizures or epileptiform discharges by complex, cognition-guided tasks, often involving visuomotor coordination and decision making [20] .
The expression of these reflex traits involving extensive networks might be indicative of different degrees of hyperexcitability in a variety of widely distributed cortical areas, allowing characterization of different endophenotypes in JME [18] .
Since none of the neuropsychological studies in JME considered the importance of the endophenotypes of the disease, this study aims to verify in a series of JME patients the possible influency of the expression of specific reflex epileptic traits on the cognitive performance.
Methods

Demographic characteristics
The inclusion criteria for the patients were age !17 years, no seizures within the 24 h preceding the day of neuropsychological evaluation, or no antihistamines or alcohol consumption within the 72 h prior to the evaluation. The exclusion criteria were the presence of other neurological disorders, alcoholism, history of drug abuse, and abnormal brain MRI scan.
A control group of 60 healthy volunteers from the community constituted the normative group. To be included in this group, the individuals should be at least 17 years old and also be of the same socio-cultural-demographic level of the patients in the other groups. Exclusion criteria were history of drug abuse, including sleeping pills, and alcoholism.
Clinical evaluation
We used a semistructured questionnaire-based interview in order to stablish the endophenotype of the disease in 61 JME patients, according to their reflex epileptic traits [21] . All patients had been unequivocally diagnosed with JME, based on electroclinical characteristics, including normal findings of physical and neurological examinations, routine blood tests, brain imaging (CT/MRI), and generalized 4-6/s spike or polyspike and waves complexes, sometimes asymmetric, on a normal background in routine EEGs [1] .
Video-EEG and endophenotypes
Once obtained the informed consent, all patients were submitted to a specific Video-EEG Neuropsychological Protocol (VNPP) based on those reported by Matsuoka et al. [22] and Mayer and Wolf [23] , described elsewhere [24] . Antiepileptic drugs (AEDs) were maintained in all patients. Video-EEG was recorded on a digital equipment (Ceegraph software, Bio-Logic Systems Corp., Mundelein, IL, U.S.A and QP-110AK Nihon Kohden, Tokyo, Japan) using the 10-20 International Electrode System, in addition to supraorbital, infraorbital and deltoid electrodes, besides palpebral electrodes [25] . After having slept for not more than 4 h, they were submitted to a 30-min awake video-EEG recording, starting at 7 a.m., followed by neuropsychological examination. The entire VNPP took 6-8 h and included tasks such as reading silently and aloud, talking, writing, performing mental and written calculations, drawing and spatial construction puzzles. The patients were randomized for the sequence of tasks.
After clinical and video-EEG analysis, JME patients were divided into four groups according to their disease endophenotypes. Group 1 included JME patients with only general precipitants of seizures, such as sleep deprivation and stress; group 2, patients with praxis and/or language sensitivity as the only reflex traits; group 3, those who expressed exclusively eye-closure sensitivity and/or photosensitivity; and, finally, in group 4, were the patients expressing a combination of traits present in groups 2 and 3.
Neuropsychological testing and psychiatric evaluation
Neuropsychological assessment included tests for intellectual level, immediate and delayed verbal and visual memories, attention, language and executive functions. We compared results of neuropsychological tests from all four JME groups to those of 60 subjects of the healthy control group (group 5).
Psychiatric comorbidity was analyzed through Schedule Clinical Interview for DSM-IV, axis I (SCID-I) [26] , and/or MINI [27, 28] and State-Trait Anxiety Inventory (STAI), composed of two scales designed to measure state (STAI-S) and trait (STAI-T) anxiety components [29] , and Beck Depression Inventory (2nd edition) [30] (Table 1) . SCID-I data were obtained from medical records in which a psychiatrist (G.M.A.F.) reported the results of a formal evaluation. A trained psychologist (K.C.C.) applied specific questionnaires such as MINI, STAI and Beck Depression Inventory.
Analysis of medications
The analysis of antiepileptic medications used by each patient was done in two steps: 1-the total amount of AEDs (as several different types were being used); 2-the total amount of sedative drugs (number and doses of different AEDs with higher sedative potential and/or interference with cognitive functions). Phenobarbital, clonazepam, clobazam and topiramate were considered AEDs with potential sedative profiles.
For quantitative evaluation of drugs administered for each patient, the concept of AED load was applied, since it is better correlated with adverse effects. AED load was calculated by summing each drug ratios of used doses and the average therapeutic doses for that drug [38] . The same calculation was separately made for the sedatives, as specified above, generating the total load of sedative medication. Therapeutic average doses considered in this study were phenobarbital 100 mg, carbamazepine 600 mg, valproate 750 mg, clobazam 15 mg, clonazepam 2 mg, topiramate 200 mg and lamotrigine 200 mg. 
Statistical analysis
The collected data were coded and entered into the SPSS 14.0 for Windows software. Initially, the results (mean AE SD) of all neuropsychological tests of healthy control subjects and patients were compared. Fisher's exact test was used for qualitative variables and one-way Analysis of Variance (ANOVA) was performed to compare quantitative variables (the detected differences were compared [post hoc] two by two using LSD multiple comparison test) of the four JME groups in demographic, clinical and neuropsychological tests. Comparison between control group and the groups of patients were performed by the one sided Dunnett Post Hoc Multiple Comparisons test. Then, raw scores on all tests for control subjects were converted to adjusted (age, gender, schooling) z scores (mean = 0, SD = 1). We also controlled myoclonia frequency, total drug doses, sedative drug doses, and age at epilepsy onset, setting these data as covariates in ANOVA. Adjusted z scores were used to provide an analysis of the cognitive status of JME patients compared with control subjects. In addition, setting all test scores with a common metric permitted us to compare directly the relative performance across de various cognitive domains, as well as to apply the definitons of abnormality (e.g., z scores !2.0) uniformly across the tests.
Later, a summary impairment index was calculated for each group. This index represents the proportion of test scores that were outside normal limits, representing the degree of cognitive morbidity exhibited by each group [39] . This index was divided in a specific impairment index, that involved each cognitive domain (memory, attention/executive function, language/fluency), and a general impairment index encompassing all the cognitive domains.
To determine the abnormality of each test, different parameters were used. A more conservative parameter considered the test result abnormal when a !2.0 SD from zero (control group) was seen. Less conservative approaches used !1.5 and !1.0 SD as parameters. The impairment index conveys the advantage of limiting the total number of comparisons conducted, therefore reducing the probability of type 1 error. The analysis of the impairment index was based on standardized scores for controls, on its three levels of restriction (!2.0, !1.5 and !1.0), also controlled by myoclonia frequency, total drug doses, sedative drug doses, and age at epilepsy onset detected by residual analysis of multiple regression through Fisher's exact test.
In all comparisons, values of p < 0.05 were considered statistically significant.
Results
Demographic and clinical features
Demographic and clinical data, as well as the pharmacological treatment of each group are presented in Tables 2, 3 and 4, respectively. The sample consisted of 61 patients (41 women), whose ages ranged from 17 to 63 years and with lengths of schooling varying between 5 and 19 years, followed in the outpatient clinic of a tertiary center (Epilepsy Section, Department of Neurology and Neurosurgery, Universidade Federal de São Paulo, São Paulo, Brazil). All the patients had been treated for [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] years (mean 9.1) in the same institution, by means of adjustment in lifestyle, being advised to avoid precipitant factors as sleep deprivation and alcohol consumption. Twenty patients constituted the group 1 while groups 2, 3, and 4 included 13, 17 and 11 patients, respectively.
Male gender prevailed in group 2 (p = 0.018) and a higher educational level was observed in group 1 (p = 0.020). There were no differences in age (p = 0.081), age at epilepsy onset (p = 0.080), epilepsy duration (p = 0.155) and family history of epilepsy (p = 0.69) ( Tables 2 and 3 ). Doses and types of AEDs were chosen according to clinical response and adverse effects. Patients received valproate as first choice AED, in mono-or polytherapy with other AEDs considered reasonably effective in JME treatment, such as lamotrigine, topiramate, phenobarbital and benzodiazepines. Mean doses of valproate were 800.0 AE 421.97, 854.2 AE 558.59, 605.9 AE 443.67 and 868.2 AE 523.10 in groups 1, 2, 3 and 4, respectively (p = 0.416) ( Table 4 ). While valproate in monotherapy was used by 73.7% of group 1 patients, two or more AEDs were taken by 58.3%, 58.8% and 54.2% of groups 2 (mean 2 AEDs), 3 and 4 (mean 3 AEDs), respectively. A greater number of patients in group 3 was using clonazepam (23.5%; p = 0.026) ( Table 4 ).
All JME groups with reflex mechanisms (2, 3 and 4) presented a higher number of patients with frequent daily myoclonia reported by approximately a quarter of the patients in group 3, when compared to group 1 (p = 0.007) ( Table 3 ); in most of them, eyelid myoclonia persisted, despite all AED attempts over the years. The other seizure types were similar among groups.
Regarding psychiatric evaluation, groups 2 and 4 showed a higher frequency of psychiatric disorders. Both had higher Beck Depression Scale scores when compared to group 3 (p = 0.034 and p = 0.005, respectively). Anxiety prevailed in group 2 (p = 0.009), while group 4 showed a higher prevalence of depression (p = 0.005) ( Table 3) .
Neuropsychological results
Intellectual function
There were no differences in mean IQ among groups of patients (p = 0.523). However, individual comparisons showed a significant difference (p = 0.017) in terms of the estimated IQ between patients with praxis and language induction (group 2) and healthy controls. Most groups of patients (1, 3 and 4) performed significantly worse on processing speed than controls (p = 0.003; p = 0.043 and p = 0.007, respectively).
Language/fluency and memory performance
Among groups, no differences were observed on memory (logical memory: immediate, p = 0.787, and delayed recall, p = 0.990; visual reproduction: immediate, p = 0.948, and delayed recall, p = 0.548) and verbal fluency (FAS, p = 0.083; animal naming, p = 0.471) (Fig. 1). 
Trail Making Test part B
Adjusting z scores for the healthy subjects group and controlling clinical variables (epilepsy onset, frequency of myoclonic seizures, total drug load and sedative drug load) highlighted Table 2 Demographic data of juvenile myoclonic epilepsy patients and control group. AEDs associated with VPA included: in Group 1, two patients used topiramate (200 mg/day and 50 mg/day); two lamotrigine (50 mg/day and 100 mg/day), three phenobarbital (100 mg/day each one) and one carbamazepine (200 mg/day) in order to control generalized tonic-clonic seizures. In Group 2, three patients used topiramate (75 mg/day, 25 mg/day and 75 mg/day); one lamotrigine (300 mg/day) and two phenobarbital (100 mg/day per patient). In Group 3, two were taking topiramate (100 mg/day and 200 mg/day); four lamotrigine (125 mg/day, 100 mg/day, 50 mg/day and 100 mg/day); four clonazepam (0.5 mg/day; 2 mg/day, 2 mg/day and 4 mg/day) and one clobazam (10 mg/day). In Group 4, two were on topiramate (100 mg/day and 75 mg/day), three lamotrigine (50 mg/day, each patient), one phenobarbital (50 mg/day), one clonazepam (9 mg/day) and one clobazam (10 mg/day). a Comparison of four JME groups using Fisher's exact test for qualitative variables. b Mean AE SD.
that JME groups differed in cognitive flexibility and processing speed, as assessed by Trail Making Test B (p = 0.027 and p = 0.035 for overall and sedative medications, respectively) ( Table 5 ). In paired analyses, group 4 patients performed worse than patients in groups 1 and 2, considering total daily doses (p = 0.008 and 0.012, respectively). When the sedative drug load was controlled, group 4 patients showed inferior performance than patients of only group 1 (p = 0.007).
Influence of controlled variables on neuropsychological results
When we controlled total drug load, early age at epilepsy onset related to worse processing speed, as assessed by Trail Making Test A (p = 0.026) and symbol search (p = 0.034), a WAIS-III task. When sedative total drug was controlled, early age at epilepsy onset related to poorer performance only in Trail Making Test A (p = 0.033). Total drug load had a negative influence on Trail Making Test, A and B (p = 0.026 and p = 0.029, respectively), and the sedative drug load showed the same effect (p = 0.018 and 0.001, respectively). Myoclonia frequency was related to worse logical memory immediate recall, and Stroop words for total drug load (p = 0.022 and p = 0.045, respectively) and sedative drug load (p = 0.029 and p = 0.025, respectively).
Impairment indexes
Adjusted z scores were used to calculate the general impairment index, based on the proportion of abnormal tests per group. Using a slightly less conservative estimate (z ! 1.5 SD), abnormal tests were found in 20.1%, 25.6%, 30.2%, and 30.3% of the patients in groups 1, 2, 3, and 4, respectively, resulting in significant difference among groups (p = 0.024). Groups 3 (p = 0.008) and 4 (p = 0.017) showed performance impairment when compared with group 1. For z ! 2.0 SD, general impairment index was abnormal in 13.8%, 15.9%, 22.4%, and 23.6% of the tests carried out with groups 1, 2, 3, and 4, respectively (p = 0.013). Groups 3 and 4 performed worse than group 1 (p = 0.010 in both) (Fig. 2) .
After controlling for clinical variables (epilepsy onset, frequency of myoclonic seizures, total drug load and sedative drug load), we calculate the same general impairment index. Using z ! 1.5 SD, abnormal tests were found in 3.8%, 6%, 5%, and 11.7% of groups 1, 2, Fig. 2 . The average proportion of abnormal adjusted z scores per group across the assessment of general impairment index, attention/executive function, language/fluency and memory impairment index in juvenile myoclonic epilepsy patients.
Comparison of the four JME groups using Fisher's exact test.
3, and 4, respectively, resulting in significant difference among groups (p = 0.017, controlled by total; and p = 0.013, by sedative drug load). Groups 1 and 3 had better performances than group 4 in this index (p = 0.004 and p = 0.019, in total drug load; p = 0.004 and p = 0.009, for sedative drug load control). For z ! 2.0 SD, general impairment index was abnormal in 1.9% of tests performed by patients in group 1, 4.8% in group 2, 2.5% in group 3, and 8.4% in group 4, considering total and sedative drug loads (p = 0.008 in both). Groups 1 and 3 had better results than group 4, considering total drug load (p = 0.002 and p = 0.014) and sedative drug load (p = 0.002 and p = 0.008) (Fig. 2) .
The groups differed significantly (p = 0.022) regarding specific impairment indexes that evaluated attention and executive function, using z ! 1.5 SD, with groups 3 and 4 performing worse than group 1 (p = 0.026 and 0.017, respectively). For z ! 2.0 SD, abnormal results were found in 20.7%, 20.9%, 32.8%, and 32.5% of the tests in groups 1, 2, 3, and 4, respectively, revealing that the groups tended to differ (p = 0.053) (Fig. 2) .
By controlling the clinical variables (epilepsy onset, frequency of myoclonic seizures, total drug load, and sedative drug load) for the specific impairment index of attention and executive function, using z ! 1.5 SD, a significant difference was observed between groups (p = 0.016 for total drug load; and p = 0.007 for sedative drug load). Group 4 showed worse performance compared to groups 1 and 3 (p = 0.004 and p = 0.021, respectively, for total load; and p = 0.002 and p = 0.012, for sedative drug load). With z ! 2.0 SD, the groups differed on both analysis (p = 0.020 for total load; and p = 0.029 for sedative drug load). Group 4 performed worse than groups 1, 2, and 3 for total drug load (p = 0.006, p = 0.036 and p = 0.046, respectively). For sedative drug load, a significant difference was only observed between groups 1 and 4, with group 4 performing worse (p = 0.040) (Fig. 2) .
Statistically, no significance was detected between the groups on tests evaluating.language/fluency (p = 0.163 for z ! 2.0 SD; p = 0.573 for z ! 1.5 SD) and memory (p = 0.520 for z ! 2.0 SD; p = 0.499 for z ! 1.5 SD) (Fig. 2) . The same occurred when we controlled for clinical variables: language/fluency (for z ! 2.0 SD p = 0.081 for both analysis; for z ! 1.5 SD, p = 0.703 for total drug load and p = 0.673 for sedative drug load) and memory (for z ! 2.0 SD p = 0.338 for both analysis; for z ! 1.5 SD, p = 0.487 for total and sedative drug load).
Discussion
The seizure-generating mechanisms of JME insult the functional-anatomical subsystems of the brain supporting central cognitive functions, like visuomotor coordination and linguistic communication, by means of genetically determined hyperexcitability and hyperconnectivity [40] . The functional and structural properties of these ictogenic networks, as well as their anatomic location, likely determine the broadly individual clinical expression and neuropsychological performance of patients with epilepsy [41] .
Demographic and clinical features
In this series, male gender prevailed in group 2 confirming findings of all other published series on praxis induction in epilepsy, at ratios of 3:1 [42] , 2.3:1 [43] , and 1.5:1 in one of our articles [44] . A higher educational level was observed in patients without reflex traits, probably reflecting a minor impact in quality of life, since all these patients had similar socio-economic backgrounds.
Regarding seizure manifestations, the three JME groups with reflex traits (groups 2, 3 and 4) presented a higher number of patients with frequent myoclonia when compared to group 1. The highest frequency of myoclonia was observed in the group of eye closure sensitivity. Other types of seizures were equally distributed across groups. Clonazepam use prevailed in the latter, since this AED, besides valproate and zonisamide, has been considered relatively effective in patients with overexpression of reflex traits [45] . For some, valproate [46] and levetiracetam [47] have been considered effective in the treatment of eyelid and photosensitivity, although difficulties in seizure control in JME patients with reflex traits have been emphasized in literature [18, 44] . A recent series from Turkey has focused on prognosis of 20 patients with eyelid and massive limb myoclonia, absences and GTCS, in a context similar to those of GGE with adolescence onset, who had been treated with several combinations of valproate, clonazepam, lamotrigine and levetiracetam. Sixteen (84%) of the patients continued presenting seizures, including GTCS, which persisted in nine (47%) of them [48] .
Patients from the present series were treated with moderate doses of AEDs, which were well tolerated, and none of them presented significant adverse effects.
Psychiatric disorders
The prevalence of clinically relevant psychiatric disorders in various series of consecutive JME patients ranges between 26.5 and 47% [49] . In this series, while patients in group 2 expressed anxiety, patients in group 4 expressed depression. Praxis induction significantly affects the quality of life of JME patients in terms of professional and leisure activities. The presence of myoclonia constantly threat patients with praxis induction in their daily activities, which might contribute for their generalized anxiety disorder [44] . However, common pathophysiological mechanisms of psychiatric disorders and JME, both related to dysfunction in fronto-thalamic circuits, might be an alternative explanation.
Neuropsychological results
This study confirms IQ preservation in JME patients, although in the lower average range, particularly in patients with praxis induction [8, 12] and differently from others, there was no difference among groups in tests evaluating hippocampal functions [13, 15] . JME patients in group 4, who expressed language/ praxis and eye closure/photo sensitivity, had a worse performance in Trail Making Test B when compared to those without any reflex trait. This result was maintained even after control for total and sedating drug daily doses, age at epilepsy onset, and seizure control. Trail Making Test B demands a complex processing that includes visuomotor coordination, sequencing, cognitive flexibility, and processing speed, and is sensitive to frontal lobe damage [50] . This particular JME group, in which more than one epileptic network seems to be involved in seizure generation as testified through specific reflex traits, also had the higher impairment in Trail Making Test B.
Moreover, a recent longitudinal study on new-onset JME reported poorer cognitive performance in patients compared to their healthy peers, and altered brain development trajectories in JME, affecting particularly higher-association fronto-parietaltemporal regions [51] . Studies on executive functions, such as planning, response inhibition, cognitive flexibility, and verbal fluency, have described varying degrees of impairment in JME and suggested that cognitive dysfunction may correlate with more active disease [8, 52, 53] . However, despite these suggestions, there is growing evidence indicating that cognitive dysfunction is part of the JME phenotype, an epilepsy syndrome that may represent a genetically determined neurodevelopmental disorder. Similar frontal lobe impairment patterns and abnormal fMRI working memory network activation are seen in siblings of JME patients who do not suffer from epilepsy [54] . Our results are also in line with the hypothesis that cognitive impairment in JME might be genetically determined, as they were independent of seizure frequency, AED doses, or age at epilepsy onset.
Trail Making Test B has been frequently used in neuropsychological research due to its reliability and sensitivity to executive dysfunction for patients with neurological disorders [50] . In a fMRI study, patients with frontal lesions showed the most consistent performance decrements in this neuropsychological test and had a more localized activation in left dorsomedial prefrontal cortex [50] . As a measure of functional deficit area of the epileptogenic zone, the present series confirms frontal dysfunction in JME [40, 55, 56] and associates this impairment with the presence of a more widespread epileptogenic network, as attested by the presence of praxis and photosensitivity in the same patients (group 4). Vollmar et al. [55] exposed 30 JME patients to a demanding frontal lobe test of visuomotor coordination and working memory. These patients and 26 healthy controls performed the task, but their fMRI showed, with a growing cognitive demand, an increasing coactivation of the primary motor cortex and supplementary motor area, as well as increased functional connectivity between the motor system and frontoparietal cognitive networks. Moreover, the concomitant physiological deactivation of the default mode network during the task was reduced [55] . The authors concluded that together these findings provide an explanation of how the cognitive effort can cause myoclonic jerks in JME. However, in JME, seizures can be induced either by complex manual activities ('praxis induction') or by language, as orofacial reflex myoclonia [56] .
Subsequent combined functional and structural connectivity analyses in JME showed decreased connectivity between the prefrontal and fronto-polar regions, possibly accounting for dysfunction of cognitive frontal lobe and impairment in executive functions, frequently reported in this epileptic syndrome [57] . Furthermore, increased connectivity was observed not only between the motor cortex and the prefrontal cortex but also between the supplementary motor area and the occipital cortex, explaining eye-closure and photo sensitivity, epileptic traits expressed by up to 15-20% and up to 50% of JME patients, respectively [40, 57, 58] .
In conclusion, the variability on executive dysfunction is a common characteristic in JME, as well as the specific modes of seizure activation. Presently considered a heterogeneous epilepsy syndrome, our results emphasize the importance of the extension and location of the abnormal epileptogenic networks, which determine not only the expression of seizures but also the neuropsychological performance. Besides that, our results are also aligned with the hypothesis that cognitive impairment may be related to clinical endophenotypes genetically determined, as it was shown to be independent of seizure frequency, AEDs doses, or age at epilepsy onset.
